Cargando…

Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity

IgG is the most prominent marker of post-COVID-19 immunity. Not only does this subtype mark the late stages of infection, but it also stays in the body for a timespan of at least 6 months. However, different IgG subclasses have different properties, and their roles in specific anti-COVID-19 response...

Descripción completa

Detalles Bibliográficos
Autores principales: Korobova, Zoia R., Zueva, Elena V., Arsentieva, Natalia A., Batsunov, Oleg K., Liubimova, Natalia E., Khamitova, Irina V., Kuznetsova, Raisa N., Rubinstein, Artem A., Savin, Tikhon V., Stanevich, Oksana V., Kulikov, Alexandr N., Pevtsov, Dmitry E., Totolian, Areg A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143443/
https://www.ncbi.nlm.nih.gov/pubmed/35632683
http://dx.doi.org/10.3390/v14050941
_version_ 1784715807488475136
author Korobova, Zoia R.
Zueva, Elena V.
Arsentieva, Natalia A.
Batsunov, Oleg K.
Liubimova, Natalia E.
Khamitova, Irina V.
Kuznetsova, Raisa N.
Rubinstein, Artem A.
Savin, Tikhon V.
Stanevich, Oksana V.
Kulikov, Alexandr N.
Pevtsov, Dmitry E.
Totolian, Areg A.
author_facet Korobova, Zoia R.
Zueva, Elena V.
Arsentieva, Natalia A.
Batsunov, Oleg K.
Liubimova, Natalia E.
Khamitova, Irina V.
Kuznetsova, Raisa N.
Rubinstein, Artem A.
Savin, Tikhon V.
Stanevich, Oksana V.
Kulikov, Alexandr N.
Pevtsov, Dmitry E.
Totolian, Areg A.
author_sort Korobova, Zoia R.
collection PubMed
description IgG is the most prominent marker of post-COVID-19 immunity. Not only does this subtype mark the late stages of infection, but it also stays in the body for a timespan of at least 6 months. However, different IgG subclasses have different properties, and their roles in specific anti-COVID-19 responses have yet to be determined. We assessed the concentrations of IgG1, IgG2, IgG3, and IgG4 against different SARS-CoV-2 antigens (N protein, S protein RBD) using a specifically designed method and samples from 348 COVID-19 patients. We noted a statistically significant association between severity of COVID-19 infection and IgG concentrations (both total and subclasses). When assessing anti-N protein and anti-RBD IgG subclasses, we noted the importance of IgG3 as a subclass. Since it is often associated with early antiviral response, we presumed that the IgG3 subclass is the first high-affinity IgG antibody to be produced during COVID-19 infection.
format Online
Article
Text
id pubmed-9143443
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91434432022-05-29 Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity Korobova, Zoia R. Zueva, Elena V. Arsentieva, Natalia A. Batsunov, Oleg K. Liubimova, Natalia E. Khamitova, Irina V. Kuznetsova, Raisa N. Rubinstein, Artem A. Savin, Tikhon V. Stanevich, Oksana V. Kulikov, Alexandr N. Pevtsov, Dmitry E. Totolian, Areg A. Viruses Article IgG is the most prominent marker of post-COVID-19 immunity. Not only does this subtype mark the late stages of infection, but it also stays in the body for a timespan of at least 6 months. However, different IgG subclasses have different properties, and their roles in specific anti-COVID-19 responses have yet to be determined. We assessed the concentrations of IgG1, IgG2, IgG3, and IgG4 against different SARS-CoV-2 antigens (N protein, S protein RBD) using a specifically designed method and samples from 348 COVID-19 patients. We noted a statistically significant association between severity of COVID-19 infection and IgG concentrations (both total and subclasses). When assessing anti-N protein and anti-RBD IgG subclasses, we noted the importance of IgG3 as a subclass. Since it is often associated with early antiviral response, we presumed that the IgG3 subclass is the first high-affinity IgG antibody to be produced during COVID-19 infection. MDPI 2022-04-29 /pmc/articles/PMC9143443/ /pubmed/35632683 http://dx.doi.org/10.3390/v14050941 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Korobova, Zoia R.
Zueva, Elena V.
Arsentieva, Natalia A.
Batsunov, Oleg K.
Liubimova, Natalia E.
Khamitova, Irina V.
Kuznetsova, Raisa N.
Rubinstein, Artem A.
Savin, Tikhon V.
Stanevich, Oksana V.
Kulikov, Alexandr N.
Pevtsov, Dmitry E.
Totolian, Areg A.
Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity
title Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity
title_full Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity
title_fullStr Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity
title_full_unstemmed Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity
title_short Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity
title_sort changes in anti-sars-cov-2 igg subclasses over time and in association with disease severity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143443/
https://www.ncbi.nlm.nih.gov/pubmed/35632683
http://dx.doi.org/10.3390/v14050941
work_keys_str_mv AT korobovazoiar changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity
AT zuevaelenav changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity
AT arsentievanataliaa changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity
AT batsunovolegk changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity
AT liubimovanataliae changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity
AT khamitovairinav changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity
AT kuznetsovaraisan changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity
AT rubinsteinartema changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity
AT savintikhonv changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity
AT stanevichoksanav changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity
AT kulikovalexandrn changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity
AT pevtsovdmitrye changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity
AT totolianarega changesinantisarscov2iggsubclassesovertimeandinassociationwithdiseaseseverity